Taken together, these findings suggest a novel mechanism to explain the functional outcome of aberrant PDGFRβ activation in perivascular cells in SSc, by demonstrating PDGF-BB-induced skewing to a Type I IFN-driven immune response. Here, PDGFRB is linked to systemic sclerosis.